MRK - Merck & Company Inc

NYSE * Healthcare * Drug Manufacturers - General

$123.51

$-0.03 (-0.02%)

About Merck & Company Inc

Merck & Company Inc (MRK) common stock

Price Chart

+%
Loading chart...

MRK Key Statistics

Market Cap

$285.12B

P/E Ratio

32.52

P/B Ratio

6.21

Dividend Yield

2.85%

How MRK Compares to Peers

P/E Rank

#4

of 6

Margin Rank

N/A

of 0

Growth Rank

N/A

of 0

Size Rank

#4

of 6

CompanyP/EGrowthCompare
MRK32.50%-
LLY39.50%vs LLY
JNJ17.40%vs JNJ
PFE19.80%vs PFE
ABBV80.50%vs ABBV
BMY17.50%vs BMY
Data Updated:
Ready to invest in MRK?

Commission-free trading available. Affiliate links.

MRK Lician Score

14% confidence
4.0/10
Neutral

MRK has a Lician Score of 4/10 (Average). Areas of concern: Growth, Quality.

value

5.0

growth

2.0

quality

2.0

momentum

5.0

safety

5.0

The Lician Score is a comprehensive 1-10 rating that evaluates MRKacross five key dimensions: Value (valuation relative to sector),Growth (revenue and earnings trajectory),Quality (profitability and balance sheet strength),Momentum (price trends and analyst sentiment), andSafety (volatility and risk metrics).

MRK Financial Snowflake

5-axis analysis across key investment dimensions

3.8/10

Poor

35810Value5.0Growth2.0Quality2.0Momentum5.0Safety5.03.8/10
5.0

Value

2.0

Growth

2.0

Quality

5.0

Momentum

5.0

Safety

Upcoming Events for MRK